Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release. / Chao, Meie; Öblom, Heidi; Cornett, Claus; Bøtker, Johan; Rantanen, Jukka; Sporrong, Sofia Kälvemark; Genina, Natalja.

I: Pharmaceutics, Bind 13, Nr. 11, 1866, 2021.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Chao, M, Öblom, H, Cornett, C, Bøtker, J, Rantanen, J, Sporrong, SK & Genina, N 2021, 'Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release', Pharmaceutics, bind 13, nr. 11, 1866. https://doi.org/10.3390/pharmaceutics13111866

APA

Chao, M., Öblom, H., Cornett, C., Bøtker, J., Rantanen, J., Sporrong, S. K., & Genina, N. (2021). Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release. Pharmaceutics, 13(11), [1866]. https://doi.org/10.3390/pharmaceutics13111866

Vancouver

Chao M, Öblom H, Cornett C, Bøtker J, Rantanen J, Sporrong SK o.a. Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release. Pharmaceutics. 2021;13(11). 1866. https://doi.org/10.3390/pharmaceutics13111866

Author

Chao, Meie ; Öblom, Heidi ; Cornett, Claus ; Bøtker, Johan ; Rantanen, Jukka ; Sporrong, Sofia Kälvemark ; Genina, Natalja. / Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release. I: Pharmaceutics. 2021 ; Bind 13, Nr. 11.

Bibtex

@article{6dc9b680f7f347aca2851d1fb5c53855,
title = "Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release",
abstract = "Data-enriched edible pharmaceuticals (DEEP) is an approach to obtain personalized medicine, in terms of flexible and precise drug doses, while at the same time containing data, embedded in quick response (QR) codes at a single dosage unit level. The aim of this study was to fabricate DEEP with a patient-tailored dose, modify drug release and design to meet patients{\textquoteright} preferences. It also aimed to investigate physical stability in terms of the readability of QR code patterns of DEEP during storage. Cannabinoids, namely, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), were used as the model active pharmaceutical ingredients (APIs). Three different substrates and two colorants for the ink were tested for their suitability to fabricate DEEP by desktop inkjet printing. Flexible doses and customizable designs of DEEP were obtained by manipulating the digital design of the QR code, particularly, by exploring different pattern types, embedded images and the physical size of the QR code pattern. Modification of the release of both APIs from DEEP was achieved by applying a hydroxypropyl cellulose (HPC) polymer coating. The appearance and readability of uncoated and polymer-coated DEEP did not change on storage in cold and dry conditions; however, the HPC polymer layer was insufficient in preserving the readability of the QR code pattern in the extreme storage condition (40 °C and 75% relative humidity). To sum up, the DEEP concept provides opportunities for the personalization of medicines, considering also patients{\textquoteright} preferences.",
keywords = "Additive manufacturing, Cannabinoids, Inkjet printing, Patient-centered pharmaceutical design, Polymer coating, QR code",
author = "Meie Chao and Heidi {\"O}blom and Claus Cornett and Johan B{\o}tker and Jukka Rantanen and Sporrong, {Sofia K{\"a}lvemark} and Natalja Genina",
note = "Funding Information: Funding: This research was funded by the NordForsk for the Nordic University Hub project #85352 (Nordic POP, Patient Oriented Products). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
doi = "10.3390/pharmaceutics13111866",
language = "English",
volume = "13",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "MDPI AG",
number = "11",

}

RIS

TY - JOUR

T1 - Data-enriched edible pharmaceuticals (Deep) with bespoke design, dose and drug release

AU - Chao, Meie

AU - Öblom, Heidi

AU - Cornett, Claus

AU - Bøtker, Johan

AU - Rantanen, Jukka

AU - Sporrong, Sofia Kälvemark

AU - Genina, Natalja

N1 - Funding Information: Funding: This research was funded by the NordForsk for the Nordic University Hub project #85352 (Nordic POP, Patient Oriented Products). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021

Y1 - 2021

N2 - Data-enriched edible pharmaceuticals (DEEP) is an approach to obtain personalized medicine, in terms of flexible and precise drug doses, while at the same time containing data, embedded in quick response (QR) codes at a single dosage unit level. The aim of this study was to fabricate DEEP with a patient-tailored dose, modify drug release and design to meet patients’ preferences. It also aimed to investigate physical stability in terms of the readability of QR code patterns of DEEP during storage. Cannabinoids, namely, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), were used as the model active pharmaceutical ingredients (APIs). Three different substrates and two colorants for the ink were tested for their suitability to fabricate DEEP by desktop inkjet printing. Flexible doses and customizable designs of DEEP were obtained by manipulating the digital design of the QR code, particularly, by exploring different pattern types, embedded images and the physical size of the QR code pattern. Modification of the release of both APIs from DEEP was achieved by applying a hydroxypropyl cellulose (HPC) polymer coating. The appearance and readability of uncoated and polymer-coated DEEP did not change on storage in cold and dry conditions; however, the HPC polymer layer was insufficient in preserving the readability of the QR code pattern in the extreme storage condition (40 °C and 75% relative humidity). To sum up, the DEEP concept provides opportunities for the personalization of medicines, considering also patients’ preferences.

AB - Data-enriched edible pharmaceuticals (DEEP) is an approach to obtain personalized medicine, in terms of flexible and precise drug doses, while at the same time containing data, embedded in quick response (QR) codes at a single dosage unit level. The aim of this study was to fabricate DEEP with a patient-tailored dose, modify drug release and design to meet patients’ preferences. It also aimed to investigate physical stability in terms of the readability of QR code patterns of DEEP during storage. Cannabinoids, namely, cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), were used as the model active pharmaceutical ingredients (APIs). Three different substrates and two colorants for the ink were tested for their suitability to fabricate DEEP by desktop inkjet printing. Flexible doses and customizable designs of DEEP were obtained by manipulating the digital design of the QR code, particularly, by exploring different pattern types, embedded images and the physical size of the QR code pattern. Modification of the release of both APIs from DEEP was achieved by applying a hydroxypropyl cellulose (HPC) polymer coating. The appearance and readability of uncoated and polymer-coated DEEP did not change on storage in cold and dry conditions; however, the HPC polymer layer was insufficient in preserving the readability of the QR code pattern in the extreme storage condition (40 °C and 75% relative humidity). To sum up, the DEEP concept provides opportunities for the personalization of medicines, considering also patients’ preferences.

KW - Additive manufacturing

KW - Cannabinoids

KW - Inkjet printing

KW - Patient-centered pharmaceutical design

KW - Polymer coating

KW - QR code

U2 - 10.3390/pharmaceutics13111866

DO - 10.3390/pharmaceutics13111866

M3 - Journal article

C2 - 34834281

AN - SCOPUS:85118770335

VL - 13

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 11

M1 - 1866

ER -

ID: 286422028